Aurora A Antikörper
Kurzübersicht für Aurora A Antikörper (ABIN2477554)
Target
Alle Aurora A (AURKA) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Kreuzreaktivität
- Maus
-
Produktmerkmale
- Purified IgG
-
Aufreinigung
- Purified
-
Isotyp
- IgG2b
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1.0 mg/mL
-
-
-
: "Aurora kinases in childhood acute leukemia: the promise of aurora B as therapeutic target." in: Leukemia, Vol. 27, Issue 3, pp. 560-8, (2013) (PubMed).
: "Inhibiting Polo-like kinase 1 causes growth reduction and apoptosis in pediatric acute lymphoblastic leukemia cells." in: Haematologica, Vol. 98, Issue 10, pp. 1539-46, (2013) (PubMed).
: "Preparation and characterization of a human aurora-A kinase monoclonal antibody." in: Molecular and cellular biochemistry, Vol. 243, Issue 1-2, pp. 123-31, (2003) (PubMed).
-
: "Aurora kinases in childhood acute leukemia: the promise of aurora B as therapeutic target." in: Leukemia, Vol. 27, Issue 3, pp. 560-8, (2013) (PubMed).
-
- Aurora A (AURKA) (Aurora Kinase A (AURKA))
-
Andere Bezeichnung
- AURORA-A KINASE
-
Hintergrund
- Synonyms: SERINE/THREONINE KINASE 15
-
Gen-ID
- 6790
-
UniProt
- O14965
-
Pathways
- Zellzyklus, Asymmetric Protein Localization
Target
-